Intravitreal dexamethasone implant Ozurdex ® in the treatment of diabetic macular edema in patients not previously treated with any intravitreal drug: A prospective 12-month follow-up study.

Conclusion: In eyes with DME not previously treated with intravitreal drugs, DEX implants provide meaningful functional and anatomical benefits, and these results are sustained mid-long-term. PMID: 31378087 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research